I now have enough material from Guyton and supporting textbooks to write comprehensive answers. Let me compile the full response.
Guyton-Based Answers: Five Topics in Medical Physiology
1. How Melatonin Regulates Circadian Rhythm
(Guyton & Hall, Chapters 59 and 60)
The Master Clock - Suprachiasmatic Nucleus (SCN)
The SCN, located in the anterior hypothalamus, serves as the primary circadian pacemaker in mammals. Its neurons generate a self-sustaining ~24-hour oscillation driven by interlocking transcription-translation feedback loops (CLOCK-BMAL1 activating Per/Cry genes, whose protein products then suppress their own transcription).
The average human SCN period is approximately 24.1 hours. Without external resetting, individuals would drift progressively out of phase with the day-night cycle.
Light Entrainment
A subset of retinal ganglion cells containing the photopigment melanopsin responds to ambient light levels. These cells project directly to the SCN via the retinohypothalamic tract. Light signals from this pathway reset the SCN clock each day to maintain synchrony with the environment.
Melatonin Synthesis and the SCN-Pineal Pathway
According to Guyton (Ch. 60):
"The SCN has multiple efferent projections that can influence sleep, including those that innervate the pineal gland, which produces melatonin during the night for induction of sleep."
The pathway is:
- SCN - neurons signal via the paraventricular nucleus
- Paraventricular nucleus - projects down the spinal cord
- Superior cervical ganglion - postganglionic sympathetic fibers
- Pineal gland - norepinephrine acts on β-adrenoceptors → increases cAMP → activates N-acetyltransferase → melatonin synthesis from serotonin
Melatonin secretion rises sharply at night (peaks ~3:00 AM) and falls during daylight hours. Light acutely suppresses melatonin - this is how the SCN signals "daytime" to the rest of the body.
How Melatonin Feeds Back to the SCN
Neurons in the SCN contain MT1 and MT2 melatonin receptors. Melatonin acts on these receptors to reinforce and stabilize the circadian rhythm. Exogenous melatonin or melatonin-receptor agonists (e.g., ramelteon) can entrain or shift circadian rhythms, which is why melatonin is used clinically for jet lag and shift-work disorder.
Downstream Relay - Sleep-Wake Control
The SCN does not directly control sleep. Instead:
- SCN (GABAergic) → subparaventricular zone (fires in antiphase, most active at night)
- Subparaventricular zone → dorsomedial nucleus of the hypothalamus
- Dorsomedial nucleus → inhibits ventrolateral preoptic nucleus (promoting wakefulness) and activates lateral hypothalamus
This relay system explains how the same SCN activity pattern can produce diurnal behavior in some species and nocturnal behavior in others.
In summary: The SCN acts as the master pacemaker → entrains to light via melanopsin-containing retinal cells → drives rhythmic melatonin secretion from the pineal gland via sympathetic innervation → melatonin feeds back to SCN receptors to reinforce the ~24-hour cycle → downstream hypothalamic relays translate this into sleep-wake, hormonal, thermal, and metabolic rhythms.
2. Hypothalamic Regulation of Body Temperature
(Guyton & Hall, Chapters 59 and 74)
The hypothalamus functions as a thermostat for the body.
Key Anatomical Regions
| Region | Function |
|---|
| Anterior hypothalamus / preoptic area | Primary thermosensitive area; responds to blood temperature; drives heat loss |
| Posterior hypothalamus | Integrates afferent temperature signals; activates heat conservation/production mechanisms |
How the Hypothalamus Detects Temperature
According to Guyton (Ch. 59):
"The anterior portion of the hypothalamus, especially the preoptic area, is concerned with regulation of body temperature. An increase in temperature of the blood flowing through this area increases activity of temperature-sensitive neurons, whereas a decrease in temperature decreases their activity."
Two classes of thermosensitive neurons are present:
- Warm-sensitive neurons (majority in preoptic area): fire faster when blood temperature rises → initiate heat-loss responses
- Cold-sensitive neurons: fire faster when blood temperature falls → initiate heat-production responses
Mechanisms Activated by the Hypothalamus
When body temperature rises (heat loss):
- Cutaneous vasodilation - increased blood flow to the skin surface
- Sweating - evaporative heat loss
- Decreased heat production - reduced shivering and metabolic activity
- Behavioral responses - seeking cooler environments
When body temperature falls (heat conservation and production):
- Cutaneous vasoconstriction - reduces heat loss from skin
- Shivering - posterior hypothalamus activates spinal cord shivering center
- Piloerection (limited in humans) - traps insulating air layer
- Increased secretion of thyroxine and epinephrine - raise metabolic rate and heat production
- Behavioral responses - seeking warmth, adding clothing
Set-Point Concept
The hypothalamus operates like a thermostat set to ~37°C. When peripheral and core temperature signals reach the preoptic area, the hypothalamus compares them to this set-point and activates corrective mechanisms accordingly.
Fever: Pyrogens (bacterial endotoxins, IL-1, TNF, prostaglandin E2) raise the hypothalamic set-point. The body then generates heat to reach the new, higher set-point. When antipyretics (aspirin, paracetamol) block prostaglandin synthesis, the set-point returns to normal and sweating/vasodilation bring temperature back down.
3. Ovulation - Definition, Hormonal Basis, and Indicators
(Guyton & Hall; Junqueira's Basic Histology)
Definition
Ovulation is the hormone-stimulated process by which the mature secondary oocyte is released from the dominant ovarian follicle. It normally occurs around day 14 of a 28-day cycle (midcycle), triggered by a surge of LH.
Just before ovulation, the dominant follicle bulges against the tunica albuginea, creating an ischemic area (the stigma), which then ruptures to release the oocyte.
Hormonal Basis (The LH Surge)
The sequence of events:
- Early follicular phase: FSH (from pituitary, stimulated by GnRH) drives development of multiple follicles
- Dominant follicle emerges: Secretes rising levels of estrogen
- Critical estrogen threshold reached: High sustained estrogen (>200 pg/mL for >36 hours) switches from negative feedback to positive feedback on the hypothalamus and pituitary
- GnRH pulse frequency increases → massive release of LH (and smaller FSH surge)
- LH surge (peaks ~24-36 hours before ovulation):
- Triggers resumption of meiosis I in the primary oocyte (completes meiosis I, arrested since fetal life)
- Increases prostaglandins → follicular wall breakdown
- Activates proteolytic enzymes (collagenase, plasminogen activator) → digest follicular wall
- Triggers ovulation ~36 hours after LH surge onset
- After ovulation: Granulosa and theca cells luteinize → form corpus luteum, which secretes progesterone (and some estrogen)
Inhibin (from granulosa and luteal cells) provides additional negative feedback on FSH.
Indicators of Ovulation
| Indicator | Basis |
|---|
| Mid-cycle LH surge (urine LH kit) | Direct hormonal detection; most reliable predictor |
| Basal body temperature (BBT) rise | Progesterone from corpus luteum is thermogenic; BBT rises 0.2-0.5°C after ovulation and remains elevated through luteal phase |
| Mittelschmerz | Mid-cycle lower abdominal/pelvic pain from follicular rupture or peritoneal irritation by follicular fluid |
| Mid-cycle spotting | Brief drop in estrogen just before/at ovulation |
| Cervical mucus changes | At ovulation: thin, clear, watery, highly stretchable (spinnbarkeit), ferning pattern on drying - under LH/estrogen influence |
| Serum progesterone | Day 21 progesterone >5 ng/mL (in a 28-day cycle) confirms ovulation has occurred |
| Ultrasound | Dominant follicle ≥20 mm prior to ovulation; follicle collapse and fluid in pouch of Douglas post-ovulation |
| Cervical os changes | Cervix becomes soft, high, and slightly open at ovulation (SHOW criteria) |
4. Uses of the EEG
(Guyton & Hall, Chapter 60)
What is the EEG?
The electroencephalogram (EEG) records electrical activity of the brain using scalp electrodes. It represents the summation of dendritic postsynaptic potentials from the superficial cortical layers rather than action potentials. Wave amplitude ranges from 0-200 microvolts; frequency ranges from <1 to >50 Hz.
Normal Brain Wave Patterns (Guyton, Ch. 60)
| Wave Type | Frequency | State |
|---|
| Alpha | 8-13 Hz | Awake, relaxed, eyes closed; occipital region |
| Beta | >14 Hz (up to 80 Hz) | Mental activity, alertness, eyes open; frontal/parietal |
| Theta | 4-7 Hz | Normal in children; emotional stress in adults; drowsiness |
| Delta | 0.5-4 Hz | Deep NREM sleep; infants; pathological in awake adults |
Clinical Uses of the EEG
1. Diagnosis and classification of epilepsy
- The single most important use. EEG shows characteristic patterns:
- Generalized tonic-clonic seizures: high-voltage spike-and-wave discharges
- Absence seizures: 3 Hz spike-and-wave pattern
- Focal/partial seizures: localized abnormal discharges identifying the seizure focus
- Helps distinguish focal from generalized epilepsy, which guides treatment
2. Localization of brain lesions
- Tumors, abscesses, and infarcts produce slow-wave (delta) activity in the overlying cortex during wakefulness, when delta should be absent
- Useful for identifying side and lobe of pathology
3. Diagnosis of encephalopathy and metabolic brain disease
- Diffuse slowing of EEG (theta/delta replacing alpha) indicates metabolic encephalopathy (e.g., hepatic encephalopathy, uremia, hyponatremia)
- Triphasic waves are characteristic of metabolic encephalopathies
4. Confirmation of brain death
- Electrocerebral silence (isoelectric/flat EEG) is one criterion used in the clinical diagnosis of brain death
5. Sleep studies (polysomnography)
- EEG identifies sleep stages (NREM stages 1-4, REM sleep), diagnoses sleep disorders such as sleep apnea, narcolepsy, and REM behavior disorder
6. Monitoring during anesthesia and surgery
- Depth of anesthesia correlates with EEG slowing (delta/burst suppression at deep anesthesia levels)
- Used during carotid endarterectomy to detect cerebral ischemia
7. Diagnosis of specific encephalitides
- Herpes simplex encephalitis: periodic lateralized epileptiform discharges (PLEDs) over temporal lobes
- Creutzfeldt-Jakob disease (prion disease): periodic sharp wave complexes
8. Neonatal monitoring
- Detects neonatal seizures (which may be subtle clinically), monitors hypoxic-ischemic encephalopathy
5. Consequences of Excess Growth Hormone After Puberty (Acromegaly)
(Guyton & Hall; Costanzo Physiology)
Key Principle
After puberty, the epiphyseal plates fuse, so linear bone growth is no longer possible. Therefore, excess GH produces acromegaly (not gigantism). The consequences are due to continued periosteal bone growth and anabolic effects of GH and IGF-1 on soft tissues and organs.
Clinical Features of Acromegaly
Skeletal changes:
- Increased periosteal bone growth - bones become thicker and wider
- Enlargement of hands and feet - rings and shoes no longer fit (classic presenting complaint)
- Prognathism - protrusion and enlargement of the jaw
- Coarsening of facial features - supraorbital ridging, enlargement of the nose
- Enlargement of frontal sinuses and mastoid air cells
- Kyphosis due to vertebral changes
Soft tissue and organ changes:
- Macroglossia - enlargement of the tongue
- Visceromegaly - enlarged heart (cardiomegaly), liver, kidneys, spleen
- Carpal tunnel syndrome - soft tissue swelling compresses the median nerve
- Skin thickening, increased sweating and sebum production
Metabolic effects:
- Insulin resistance and glucose intolerance - GH is a counter-regulatory hormone that opposes insulin; chronic excess leads to impaired glucose tolerance or frank diabetes mellitus (diabetogenic effect)
- Increased lipolysis - mobilization of fatty acids
- Positive nitrogen balance (anabolic effect)
Cardiovascular effects:
- Cardiomegaly → cardiomyopathy, heart failure
- Hypertension
- Increased risk of arrhythmias
Respiratory:
- Sleep apnea - due to macroglossia, enlarged soft tissues of the pharynx
Reproductive:
- Menstrual irregularities in women
- Impotence in men (often due to co-secretion of prolactin by mixed adenomas, or from hypogonadism)
Neurological:
- Headache (from the pituitary tumor itself)
- Bitemporal hemianopia - if the tumor compresses the optic chiasm
- Peripheral neuropathy
Cause and Treatment
The most common cause is a GH-secreting pituitary somatotroph adenoma. Treatment options include:
- Somatostatin analogues (octreotide, lanreotide) - mimic endogenous somatostatin to suppress GH secretion
- Surgery (transsphenoidal adenomectomy) - first-line if resectable
- GH receptor antagonist (pegvisomant) - blocks peripheral GH action
- Radiotherapy - for residual tumor
Sources: Guyton and Hall Textbook of Medical Physiology, 14e (Chs. 59, 60, 74, 76); Ganong's Review of Medical Physiology, 26e; Costanzo Physiology, 7e; Junqueira's Basic Histology, 17e; Eric Kandel, Principles of Neural Science, 6e.